Navigation Links
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
Date:7/31/2013

of drug products such as OFIRMEV, and the potential implementation by regulatory agencies of new requirements to include unfavorable information in the labeling for OFIRMEV; the risk that Cadence may not be able to raise sufficient capital when needed, or at all; and other risks detailed under "Risk Factors" and elsewhere in Cadence's periodic reports and other filings made with the Securities and Exchange Commission from time to time. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995, and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Cadence® and OFIRMEV® are trademarks of Cadence Pharmaceuticals, Inc. Contact:

William R. LaRue 

Kelli FranceSVP & Chief Financial Officer 

Media RelationsCadence Pharmaceuticals, Inc. 

WCGPhone: 858-436-1400 

Phone:  415-946-107 CADENCE PHARMACEUTICALS, INC.CONDENSED STATEMENTS OF OPERATIONS(unaudited)(in thousands, except per share amounts)Three Months EndedSix Months EndedJune 30,June 30,2013201220132012Revenues:Product revenue, net

$   24,674$   11,075$   48,286$   19,079License revenue

-33-33Total revenues

24,67411,10848,28619,112Costs and expenses:Cost of product sales

8,2945,75616,46110,002Amortization of patent license

336336672672Research and development

1,6801,7003,0433,211Selling, general and administrative

25,69823,24147,33346,772Other

(545)1(495)1Total costs and expenses

35,46331,03467,01460,658Loss from operations

(10,789)(19,926)(18,728)(41,546)Other (expense) income, net

(1,086)(1,063)5,490(2,116)Net loss

$  (11,875)$  (2
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
8. Cadence to Open Finished Medical Device Facility
9. Cadence Pharmaceuticals to Host Analyst and Investor Day
10. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
11. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- The ... by universal healthcare coverage and good access to ... population and its associated disease burden, well-defined regulatory ... introduction of a new manufacturing policy will drive ... However, a focus on generic substitution and price ...
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... , Sept. 2, 2014  Based on ... treatment device market, Frost & Sullivan recognizes Novian ... & Sullivan Award for Technology Innovation Leadership. Novian ... fibroadenoma and malignant tumors with its proprietary technology, ... is a reliable, accurate, and easy-to-control ultrasound-guided thermo ...
Breaking Medicine Technology:Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 2Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 3Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 4Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 5ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5
... , CINCINNATI , June 21 ... to its HARMONIC® line of surgical devices, the HARMONIC ... designed to extend the reach of surgeons for minimally ... (or 9cm) than the standard length HARMONIC ACE® device. ...
... today announced that six-month clinical follow-up data show the safety and ... (Sequent Please®, B.Braun) followed by implantation of the company,s Genous Bio-engineered ... , , ... single center, all-comers POTENT ( P aclitaxel-eluting ball O on and ...
Cached Medicine Technology:Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 2Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 3Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 2Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 3
(Date:9/2/2014)... 2014 Recently, Top 10 Best ... and announced that JustHost ( http://www.justhost.com/track/seohosts ) and ... , “The hosting suppliers we recommend are the ... on hosting features, uptime and server speed with ... SEO Hosting says. “We believe that BlueHost and ...
(Date:9/2/2014)... DC (PRWEB) September 02, 2014 TCG, a ... by Inc. 5000 as one of the fastest-growing companies in ... eighth time total. TCG was previously recognized in 2013, 2012, ... , TCG’s revenue has grown 86% from 2010 to 2013, ... the fastest growing businesses in America - up 635 spots ...
(Date:9/2/2014)... Cloud Medical Doctor Software Corporation (Cloud-MDs) ... Practice Business Operations solutions and Billing Services for the ... solutions for all industries announced today that its CEO ... of the CME in Chicago by PRICE Futures Group ... are very proud of the recognition that our CipherLoc ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The Wm. Jennings ... fair and public town hall meeting for Veterans and their ... at the outreach fair to provide Veterans with valuable healthcare ... “The town hall will provide a forum where we can ... programs.” , The outreach fair will be held 4:45 p.m. ...
(Date:9/2/2014)... News) -- Complications are rare among breast cancer ... study indicates. However, the researchers did find ... slightly higher risk for certain complications than a ... 18,000 breast cancer patients who had a single ... reconstruction and were followed for 30 days after ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2
... of some on the market , WEDNESDAY, Oct. 14 (HealthDay ... House Office of Management and Budget, is reported to drink ... genetic test to see if his body could metabolize his ... body is perfectly suited to the task, and Orszag can ...
... emerged from 47,000 votes on over 700 essay entries as ... essay contest. The essay contest awards each winner $1,000 ... make life easier for those affected by breast cancer. , ... memory to taking a supportive child to Disney World to ...
... ... hold employment to persevere in this difficult job market. Profiles International suggests that employees ... , ... October 14, 2009 -- Profiles International, a developer of employee assessments and ...
... ... in Class Alzheimer,s Care , ... Neenah, Wisc. (Vocus) October 14, 2009 -- Tracy Hoffman, M.D., one of the nation,s premier ... innovator with 16 facilities in Wisconsin and Illinois. , , , , ,As Corporate Director ...
... ... sleeping problems report better sleep with Gene-Eden, a natural supplement that targets many common chronic ... Rochester, NY (PRWEB) ... natural antiviral Gene-Eden. Analysis of the interviews revealed that the users of the supplement experience ...
... ... Management,(School for Managers) to be held at Sheraton, Wakefield, MA, , ... Boston, MA (PRWEB) October 14, 2009 ... training program, ,Strategic Problem Solving & Advanced Time Management, to be held Wednesday, November ...
Cached Medicine News:Health News:Are Commercial Genetic Tests Worth Taking? 2Health News:Are Commercial Genetic Tests Worth Taking? 3Health News:Fifteen Women Win National O-Cedar(R) Essay Contest 2Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 2Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 3Health News:Renowned Geriatrician Tracy Hoffman Tapped as Corporate Director of Memory Care Excellence By Fast-Growing CRL 2Health News:Renowned Geriatrician Tracy Hoffman Tapped as Corporate Director of Memory Care Excellence By Fast-Growing CRL 3Health News:Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study 2Health News:Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study 3Health News:One Day Management Training Program to be Offered November 18 in Boston Area 2Health News:One Day Management Training Program to be Offered November 18 in Boston Area 3Health News:One Day Management Training Program to be Offered November 18 in Boston Area 4Health News:One Day Management Training Program to be Offered November 18 in Boston Area 5
Female Compression VEST w/sleeves...
Male Support Brief...
Ideal for lower abdominal procedures. Comes with a left side separating zipper....
Arm Compression Garment...
Medicine Products: